Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

i-SENS, Inc.

Home Clinical Trial Sponsors and Organizationsi-SENS, Inc.

i-SENS, Inc.

43 Banpo-daero 28-gil, Seocho-gu, Seoul, South Korea

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

5

62.5%

Unknown

3

37.5%

Trial Status Distribution

Completed

4

50.0%

Not yet recruiting

2

25.0%

Recruiting

1

12.5%

Terminated

1

12.5%

Clinical Trials

Trials sponsored by this organization (8)

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Feb 202632 participants

A prospective, monocenter, single-arm, open-label, interventional, post-market follow-up evaluation of the CareSens Air continuous glucose monitoring system in adult patients with type 1 and type 2 diabetes

Not yet recruiting

Jul 202430 participants

Evaluation of a Novel Continuous Glucose Monitoring System in Children and Adults with Type 1 and Type 2 Diabetes

Not yet recruiting

Jun 2024100 participants

A prospective, monocenter, single-arm, open-label study to collect data for algorithm optimization of the Continuous Glucose Monitoring System CareSens Neon in adult patients with type 1 diabetes

Jun 202323 participants

Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System

Aug 202276 participants

A prospective, single arm, open-label, interventional, pivotal study to evaluate the efficacy and safety of the Continuous Glucose Monitoring System ‘CareSens Air’ in adult patients with type 1 and type 2 diabetes

Apr 202250 participants

Evaluation of the efficacy and safety of a new Continuous Glucose Monitoring System in adult patients with type 1 and type 2 diabetes

Feb 202269 participants

Algorithm optimization of a new continuous glucose monitoring system in children, adolescents and adult patients with type 1 diabetes – A pilot study.

Jun 202130 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations